Emerging drugs for Hodgkin's lymphoma.

IMPORTANCE OF THE FIELD Although to date most patients with Hodgkin's lymphoma (HL) can be cured, the current treatment is associated with acute and long-term complications such as infertility, cardiovascular damage and secondary malignancies. Moreover, novel effective therapies are urgently needed for elderly patients and for patients relapsing after high… CONTINUE READING